Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Clinical trial NCT07400458 · RECRUITING

Trial details

NCT number: NCT07400458
Sponsor: Pharmicell Co., Ltd.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myocardial Infarction

Start date: 2022-03-03
Primary completion: 2028-10-12
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.